Publication
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis
David Rosenfield, Jasper A.J. Smits, Stefan G. Hofmann, David Mataix-Cols, Lorena Fernández de la Cruz, Erik Andersson, Christian Rück, Benedetta Monzani, Ana Pérez-Vigil, Paolo Frumento, Michael Davis, Rianne A. de Kleine, JoAnn Difede, Boadie W. Dunlop, Lara J. Farrell, Daniel Geller, Maryrose Gerardi, Adam J. Guastella, Gert-Jan Hendriks, Matt G. Kushner, Francis S. Lee, Eric J. Lenze, Cheri A. Levinson, Harry McConnell, Jens Plag, Mark H. Pollack, Kerry J. Ressler, Thomas L. Rodebaugh, Barbara O. Rothbaum, Eric A. Storch, Andreas Ströhle, Candyce D. Tart, David F. Tolin, Agnes van Minnen, Allison M. Waters, Carl F. Weems, Sabine Wilhelm, Katarzyna Wyka, Margaret Altemus, Page Anderson, Judith Cukor, Claudia Finck, Gary R. Geffken, Fabian Golfels, Wayne K. Goodman, Cassidy A. Gutner, Isobel Heyman, Tanja Jovanovic, Adam B. Lewin, Joseph P. McNamara, Tanya K. Murphy, Seth Norrholm, Paul Thuras, Cynthia Turner, Michael W. Otto
Journal of Anxiety Disorders, December 2019, Elsevier
DOI: 10.1016/j.janxdis.2019.102149